Delta 9 Cannabis Future Growth
Future criteria checks 1/6
Delta 9 Cannabis wird voraussichtlich ein Umsatzwachstum verzeichnen at 8.4% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 37.0% |
| Revenue growth rate | 10.0% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 16 Nov 2023 |
Recent future growth updates
Recent updates
Delta 9 Cannabis Inc.'s (TSE:DN) Shares Leap 122% Yet They're Still Not Telling The Full Story
Mar 26
Market Might Still Lack Some Conviction On Delta 9 Cannabis Inc. (TSE:DN) Even After 122% Share Price Boost
Mar 26Is Delta 9 Cannabis (TSE:DN) Using Too Much Debt?
Sep 09Delta 9 Cannabis Inc. (TSE:DN) Not Doing Enough For Some Investors As Its Shares Slump 27%
Jul 28Does Delta 9 Cannabis (TSE:DN) Have A Healthy Balance Sheet?
Aug 19Is Delta 9 Cannabis (TSE:DN) A Risky Investment?
Jan 11Delta 9 Cannabis (TSE:DN) Is Making Moderate Use Of Debt
Sep 28Delta 9 Cannabis (TSE:DN) Is Carrying A Fair Bit Of Debt
Apr 08John Arbuthnot Is The Co-Founder of Delta 9 Cannabis Inc. (TSE:DN) And They Just Picked Up 1.0% More Shares
Dec 24
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 87 | N/A | N/A | N/A | 1 |
| 12/31/2024 | 76 | N/A | N/A | N/A | 1 |
| 12/31/2023 | 71 | -18 | 4 | 4 | N/A |
| 9/30/2023 | 71 | -22 | 4 | 5 | N/A |
| 6/30/2023 | 68 | -24 | 3 | 4 | N/A |
| 3/31/2023 | 68 | -26 | -3 | -1 | N/A |
| 12/31/2022 | 63 | -27 | -6 | -4 | N/A |
| 9/30/2022 | 63 | -21 | -7 | -5 | N/A |
| 6/30/2022 | 62 | -14 | -8 | -6 | N/A |
| 3/31/2022 | 62 | -11 | -4 | -1 | N/A |
| 12/31/2021 | 62 | -11 | -3 | -1 | N/A |
| 9/30/2021 | 59 | -8 | -6 | -2 | N/A |
| 6/30/2021 | 57 | -12 | -6 | -3 | N/A |
| 3/31/2021 | 54 | -13 | -7 | -2 | N/A |
| 12/31/2020 | 52 | -6 | -4 | 2 | N/A |
| 9/30/2020 | 48 | -8 | -6 | 0 | N/A |
| 6/30/2020 | 42 | -4 | -10 | 1 | N/A |
| 3/31/2020 | 38 | -3 | -16 | -3 | N/A |
| 12/31/2019 | 32 | 11 | -26 | -12 | N/A |
| 9/30/2019 | 26 | 12 | -34 | -10 | N/A |
| 6/30/2019 | 21 | 11 | -35 | -14 | N/A |
| 3/31/2019 | 13 | 10 | -35 | -15 | N/A |
| 12/31/2018 | 8 | -8 | -26 | -9 | N/A |
| 9/30/2018 | 3 | -12 | -16 | -11 | N/A |
| 6/30/2018 | 2 | -11 | -10 | -7 | N/A |
| 3/31/2018 | 1 | -9 | -7 | -5 | N/A |
| 12/31/2017 | 1 | -8 | -5 | -5 | N/A |
| 9/30/2017 | 1 | -2 | N/A | -3 | N/A |
| 6/30/2017 | 1 | -2 | N/A | -2 | N/A |
| 3/31/2017 | 1 | -1 | N/A | -1 | N/A |
| 12/31/2016 | 0 | -1 | N/A | -1 | N/A |
| 12/31/2015 | 1 | -1 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Einkommen vs. Sparrate: Unzureichende Daten, um festzustellen, ob das prognostizierte Gewinnwachstum von DN über der Sparquote liegt (1.9%).
Ertrag vs. Markt: Unzureichende Daten, um festzustellen, ob die Gewinne von DN schneller wachsen werden als der Markt Canadian
Hohe Wachstumserträge: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von DN in den nächsten 3 Jahren signifikant steigen werden.
Einnahmen vs. Markt: DNDie Einnahmen des Unternehmens (8.4% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Canadian (6.8% pro Jahr).
Hohe Wachstumseinnahmen: DNDie Einnahmen des Unternehmens (8.4% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Earnings per Share Growth Forecasts
Future Return on Equity
Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von DN in 3 Jahren voraussichtlich hoch sein wird